ZENTALIS PHARMACEUTICALS INC. - COMMON STOCK

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Jan 2023 17:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Dec 2022 17:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates

09 Nov 2022 07:00:02 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in the Stifel 2022 Healthcare Conference

08 Nov 2022 07:01:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Nov 2022 17:38:22 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces First ZN-c3 Clinical Development Collaboration with Pfizer

24 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Dr. Mark Lackner as Chief Translational Officer, Head of Biomarker Strategy

17 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Oct 2022 17:32:42 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Promotes Co-Founder Kevin Bunker, Ph.D. to Chief Scientific Officer

27 Sep 2022 16:01:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Dr. Carrie Brownstein as Chief Medical Officer

19 Sep 2022 07:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Dr. Jan Skvarka to its Board of Directors

12 Sep 2022 07:00:01 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01 Sep 2022 17:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences

31 Aug 2022 07:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update

09 Aug 2022 16:01:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Conference

03 Aug 2022 07:00:01 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01 Aug 2022 17:10:35 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Andrea Paul as General Counsel and Corporate Secretary

27 Jun 2022 07:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in the Jefferies Healthcare Conference

01 Jun 2022 07:00:01 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Promotes Cofounder Cam Gallagher to President

31 May 2022 07:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Closing of Underwritten Offering of Common Stock

18 May 2022 16:01:00 By Nasdaq GlobeNewswire